GIP (1-30) amide, porcine, is primarily used in research settings to study its physiological roles and potential therapeutic applications. It is a peptide fragment of gastric inhibitory polypeptide (GIP), which plays a significant role in glucose metabolism and insulin secretion. Researchers utilize this compound to investigate its effects on insulin release, particularly in the context of diabetes management. Additionally, it is employed in studies exploring its impact on fat metabolism and energy homeostasis, as GIP is known to influence adipose tissue function. The porcine-derived peptide is often used in animal models to mimic human physiological responses, aiding in the development of treatments for metabolic disorders. Its application extends to understanding the mechanisms of GIP receptor signaling and its potential as a target for drug development in conditions like type 2 diabetes and obesity.